Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conference
- AACR abstract to highlight the Company’s progress with proprietary gene circuit engineered allogeneic CAR-NK cell therapy pipeline - SOUTH SAN FRANCISCO, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today …